All Online

1 - 12 of 24 results

Refine

Active filters

2019 novel coronavirus, SARS-CoV-2
0.5 CME CREDIT

In the fourteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the recent data on COVID-19 and children. This presentation will cover the typical presentation of COVID-19 in children and review the risk and mechanisms of Multisystem Inflammatory Syndrome in Children (MIS-C).


0.5 CME CREDIT

In the twenty-fifth episode of Pri-Med’s web series on COVID-19, faculty will approach the emerging and concerning concept of “long-haul” COVID-19. Additionally, this session will discuss postural orthostatic tachycardia syndrome (POTS) and the mechanisms connecting SARS-CoV-2 infection to POTS. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 02/09/2021 and they are subject to change as new information is published.


1 CME CREDIT

COVID-19 Panel Discussion: February 2021

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care, and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss how seropositivity levels can vary after vaccination and which patients would make good candidates for monoclonal antibodies (mAbs). You’ll also hear the latest clinical trials data on the efficacy of mAbs.


1 CME CREDIT

COVID-19 Vaccines: Science vs. Anti-Science

Featuring Peter J. Hotez, MD, PhD

1.00 CME/MOC
1.00 AANP | 0.40 Pharmacology

Globally, we are seeing a mixed picture of vaccinating the United States and the world against COVID-19, with tremendous progress containing the B.1.1.7 variant in the United States but failing to control widespread transmission in Africa and Latin America. Dr. Hotez will discuss the progress made to date with the US vaccination program, what we can expect toward the end of 2021 and into 2022, and how we can advance vaccinations globally. This session will also explore the impact of a rising and shifting anti-vaccine movement.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the incidence and clinical features of vaccine-induced thrombotic thrombocytopenia (VITT) and the epidemiology and treatment of emerging COVID-19 variants.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the use of the COVID-19 vaccine in two important patient populations: adolescents and pregnant women. You’ll also hear the latest guidance on when to wear a mask.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the most common reactions to the two approved COVID-19 mRNA vaccines, as well as evaluate the data on the efficacy of zinc and vitamin C on outpatients and single high dose of vitamin D among inpatients with SARS-CoV-2 infection.


1 CME CREDIT

These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care, and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.


image of kids getting their temperature checked
0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss how the post-acute sequalae of COVID-19 (PASC) and trends, prevention, and treatment of COVID-19 infection among children and young people.


1 CME CREDIT

Clinicians often find themselves navigating a gauntlet of choices when recommending over the counter (OTC) medications for an acute viral respiratory illness. Decisions about NSAIDs, acetaminophen and aspirin to manage pain, inflammation and fever may now be more complicated given the COVID-19 pandemic. This session will dispel common misunderstandings about pain and fever reducing medications, with a focused discussion on some of the recent misconceptions surrounding NSAID use in relation to COVID-19. Faculty will present appropriate applications of NSAIDs and acetaminophen, based on current literature and evidence-based data.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the use of the COVID-19 vaccine in two important patient populations: adolescents and pregnant women. You’ll also hear the latest guidance on when to wear a mask.